DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @BlogYomi | 9 |
| @thefinreviewer | 7 |
| @TheMarketsDaily | 4 |
| @bibeypost_stock | 4 |
| @macondailynews | 3 |
Recent Tweets for FATE
 |
@JRMKE_ @TomSilver39 Are you sure $FATE is presenting here? I didn’t hear anything during their latest CC about this confer… https://t.co/hSdSiZhoRO April 22nd 2019, 4:04pm |
 |
@FinZTribune Ionis Pharmaceuticals Inc. $FATE https://t.co/VQkVgRx0IW April 22nd 2019, 4:04pm |
 |
@SwingTradeBot 50 DMA Resistance today: $FATE $RRGB ... https://t.co/mnYaiRq1wk April 22nd 2019, 11:04am |
 |
@macondailynews Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/6LtejWenmr April 22nd 2019, 5:04am |
 |
@stocknewstimes Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/ZyKANpT8wX April 22nd 2019, 4:04am |
 |
@TranscriptDaily Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/iaTNGUnNqV April 22nd 2019, 4:04am |
|
@macondailynews Analysts Anticipate Fate Therapeutics Inc $FATE Will Announce Quarterly Sales of $2.94 Million https://t.co/dWkmSldz8X April 21st 2019, 10:04pm |
 |
@TheMarketsDaily Zacks: Analysts Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $2.94 Million https://t.co/rt3ruB7tDi April 21st 2019, 10:04pm |
 |
@dakotafinancial Brokerages Expect Fate Therapeutics Inc $FATE Will Post Earnings of -$0.23 Per Share https://t.co/EVus8TTHwJ April 21st 2019, 10:04pm |
|
@TheMarketsDaily Fate Therapeutics Inc $FATE CEO J Scott Wolchko Sells 8,541 Shares https://t.co/iL03it3jie April 21st 2019, 5:04am |
 |
@ZolmaxNews J Scott Wolchko Sells 8,541 Shares of Fate Therapeutics Inc $FATE Stock https://t.co/sbnS45nobT April 21st 2019, 5:04am |
 |
@1MinuteStock Explore #fundamental numbers and pros and cons for $FATE https://t.co/J4oHx27FTs April 21st 2019, 12:04am |
|
@1MinuteStock Recommendation Moderate #SELL for $FATE with UB rating - 1.56 out of 5. https://t.co/b2bTDHWFZe April 20th 2019, 11:04pm |
 |
@ZG121015 $FATE stochastic buy with hammer candle. https://t.co/UoqtMJn7CO April 20th 2019, 8:04pm |
|
@dakotafinancial Fate Therapeutics Inc $FATE CEO J Scott Wolchko Sells 8,541 Shares https://t.co/3QZPONlZ7x April 20th 2019, 9:04am |
 |
@ConsumerFeed Fate Therapeutics CEO J Scott Wolchko Sells $138,107.97 in $FATE https://t.co/s7hqdXixNN April 20th 2019, 3:04am |
 |
@insiderbuyings $FATE new insider selling: 20000 shares. https://t.co/TtsVriQRXT April 19th 2019, 10:04pm |
 |
@ThisLincolnian Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/8viZbRKItS April 19th 2019, 5:04pm |
 |
@AmericanBanking J Scott Wolchko Sells 8,541 Shares of Fate Therapeutics Inc $FATE Stock https://t.co/ibq7dAJ0wX #stocks April 19th 2019, 5:04pm |
 |
@WeekHerald J Scott Wolchko Sells 8,541 Shares of Fate Therapeutics Inc $FATE Stock https://t.co/yjq58fL2zN April 19th 2019, 5:04pm |
 |
@InsiderAlertsIA $FATE: New Insider Filing on President and CEO J SCOTT WOLCHKO: https://t.co/9UQTN5EW9a April 19th 2019, 4:04pm |
 |
@EdgarPulse $FATE: Wolchko J Scott (CEO) disposed stocks worth $321,641 https://t.co/b5K7Rn07dY April 19th 2019, 4:04pm |
 |
@dispatchtribune -$0.23 EPS Expected for Fate Therapeutics Inc $FATE This Quarter https://t.co/4KAkvr1Eoz April 19th 2019, 1:04pm |
 |
@BlindSpotFunds @B3_MillerValue When $FATE was bottoming, there were many internet blogger's, like @adamfeuerstein, pointing at it… https://t.co/9KEp2fpPUp April 19th 2019, 1:04pm |
|
@WeekHerald Zacks: Brokerages Anticipate Fate Therapeutics Inc $FATE Will Announce Quarterly Sales of $2.94 Million https://t.co/NXMTCv7CdY April 19th 2019, 1:04pm |
 |
@OlympiaReport Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $2.94 Million https://t.co/AOKn2BgISB April 19th 2019, 1:04pm |
|
@TheMarketsDaily Fate Therapeutics $FATE Trading Down 5.4% https://t.co/wSARRl01sT April 19th 2019, 10:04am |
|
@macondailynews Fate Therapeutics $FATE Trading Down 5.4% https://t.co/upM9h2MDLv April 19th 2019, 10:04am |
 |
@TradeFlags TD BUY $FATE at 16.02, Supp 15.61 Resis 18.45 R18 HiLo 71% T1Y 21 strong_buy 1.5 fwdPE -15.3 DIV N/A #Fate Thera… https://t.co/v3wfo9Yekp April 18th 2019, 10:04pm |
 |
@thefinreviewer Reviewing Pluristem Therapeutics Inc. $FATE's results https://t.co/fVCoUm6dFn April 18th 2019, 10:04pm |
 |
@BlogYomi iBio Inc. $FATE Contrasting side by side https://t.co/CNJyZKkOSl April 18th 2019, 10:04pm |
 |
@American_Bulls $FATE the bull pattern is not confirmed. A new bull pattern is detected. https://t.co/uZaWMEAfZz April 18th 2019, 7:04pm |
|
@BlogYomi Fate Therapeutics $FATE Share Price Rose While Polaris Venture Management Company Decreased by $7.80 Million Its S… https://t.co/SRqLD9rsMH April 18th 2019, 3:04pm |
 |
@reurope_stock Were Analysts Bullish Fate Therapeutics, Inc. $FATE This Week? https://t.co/q5wBW8uw5y April 18th 2019, 10:04am |
 |
@HottestStockNow $FATE Makes Strategic Move https://t.co/7aIBrwE3GW April 18th 2019, 9:04am |
 |
@StockTexts $FATE Fate Therapeutics Appoints Wayne Chu, M.D. as Vice President, Clinical Development Nasdaq:FATE https://t.co/ksvcc7f8Kw April 18th 2019, 8:04am |
|
@thefinreviewer Farallon Capital Management Stake in Fate Therapeutics $FATE Boosted as Market Valuation Rose; Paccar $PCAR Stake M… https://t.co/9FwgIdNr1h April 18th 2019, 5:04am |
|
@TranscriptDaily Fate Therapeutics $FATE Trading Down 5.4% https://t.co/X4ZCG9bJjc April 17th 2019, 7:04pm |
|
@American_Bulls $FATE apparently the bull pattern is not confirmed. Prices continue to fall. https://t.co/uZaWMEAfZz April 17th 2019, 6:04pm |
|
@BlogYomi As Fate Therapeutics $FATE Valuation Rose, Polaris Venture Management Company Decreased by $7.80 Million Its Posit… https://t.co/BKy39iwwv6 April 17th 2019, 2:04pm |
 |
@mmahotstuff1 Polaris Venture Management Company Cut Stake in Fate Therapeutics INC $FATE by $7.80 Million as Stock Rose https://t.co/K36tGakSET April 17th 2019, 2:04pm |
 |
@bibeypost_stock Fate Therapeutics INC $FATE Shareholder Polaris Venture Management Company Cut Its Holding https://t.co/05MyF0aLzh April 17th 2019, 2:04pm |
 |
@whatsonthorold2 Time to Buy Fate Therapeutics, Inc. $FATE After Today's Huge Decline? https://t.co/k2raSNoFeU April 17th 2019, 1:04pm |
|
@ConsumerFeed Brokerages Expect Fate Therapeutics Inc $FATE to Announce -$0.23 EPS https://t.co/HlmUv2HZ1y April 17th 2019, 5:04am |
|
@thefinreviewer As Fate Therapeutics $FATE Market Valuation Rose, Polaris Venture Management Company Has Trimmed Its Holding by $7… https://t.co/LRtLd51tDK April 17th 2019, 5:04am |
|
@BlogYomi Reviewing NanoString Technologies Inc. $FATE's results https://t.co/6sDjvK0WDy April 16th 2019, 7:04pm |
|
@thefinreviewer Intrexon Corporation $FATE Comparing side by side https://t.co/VQqeK4Y7wJ April 16th 2019, 5:04pm |
|
@stocknewstimes Fate Therapeutics Inc $FATE Expected to Announce Quarterly Sales of $2.94 Million https://t.co/9S9hbHJWzJ April 16th 2019, 2:04am |
|
@AmericanBanking Fate Therapeutics Inc $FATE Expected to Announce Quarterly Sales of $2.94 Million https://t.co/lyK1QwyppH #stocks April 16th 2019, 2:04am |
|
@TranscriptDaily Brokerages Anticipate Fate Therapeutics Inc $FATE Will Announce Quarterly Sales of $2.94 Million https://t.co/2G0Nx4IaE4 April 16th 2019, 2:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.